BOOTHBAY FUND MANAGEMENT, LLC - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 40 filers reported holding DIAMEDICA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$52,000
-32.5%
20,6030.0%0.00%
-50.0%
Q4 2021$77,000
-37.9%
20,603
-33.3%
0.00%
-33.3%
Q3 2021$124,000
-40.1%
30,904
-33.6%
0.00%
-57.1%
Q2 2021$207,000
-51.4%
46,5620.0%0.01%
-56.2%
Q1 2021$426,000
-9.7%
46,5620.0%0.02%
-11.1%
Q4 2020$472,000
+139.6%
46,5620.0%0.02%
+50.0%
Q3 2020$197,00046,5620.01%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,197,245$2,993,0001.24%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 265,000$663,0000.40%
COOPERMAN LEON G 812,508$2,031,2700.11%
Ikarian Capital, LLC 221,252$553,0000.07%
Shay Capital LLC 10,000$25,0000.00%
Sandy Cove Advisors, LLC 1,200$3,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,603$52,0000.00%
Newbridge Financial Services Group, Inc. 1,269$3,0000.00%
Patriot Financial Group Insurance Agency, LLC 1,300$3,0000.00%
GROUP ONE TRADING, L.P. 20$00.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders